Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease

Lewis, Frank, Fairooz, Safiya, Elson, Joanna L., Hubscher-Bruder, Véronique, Brandel, Jeremy, Soundararajan, Meera, Smith, David, Dexter, David T., Tétard, David and Pienaar, Ilse S. (2020) Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease. Archives of Toxicology, 94 (3). pp. 813-831. ISSN 0340-5761

[img]
Preview
Text (Final published version)
Lewis2020_Article_Novel1-hydroxypyridin-2-oneMet.pdf - Published Version
Available under License Creative Commons Attribution 4.0.

Download (3MB) | Preview
[img]
Preview
Text (Advance online version)
Lewis2020_Article_Novel1-hydroxypyridin-2-oneMet.pdf - Published Version
Available under License Creative Commons Attribution 4.0.

Download (3MB) | Preview
Official URL: https://doi.org/10.1007/s00204-020-02672-y

Abstract

Ubiquitin proteasome system (UPS) impairment, excessive cellular oxidative stress, and iron dyshomeostasis are key to substantia nigra dopaminergic neuronal degeneration in Parkinson's disease (PD); however, a link between these features remains unconfirmed. Using the proteasome inhibitor lactacystin we confirm that nigral injury via UPS impairment disrupts iron homeostasis, in turn increasing oxidative stress and promoting protein aggregation. We demonstrate the neuroprotective potential of two novel 1-hydroxy-2(1H)-pyridinone (1,2-HOPO) iron chelators, compounds C6 and C9, against lactacystin-induced cell death. We demonstrate that this cellular preservation relates to the compounds’ iron chelating capabilities and subsequent reduced capacity of iron to form reactive oxygen species (ROS), where we also show that the ligands act as antioxidant agents. Our results also demonstrate the ability of C6 and C9 to reduce intracellular lactacystin-induced α-synuclein burden. Stability constant measurements confirmed a high affinity of C6 and C9 for Fe3+ and display a 3:1 HOPO:Fe3+ complex formation at physiological pH. Reducing iron reactivity could prevent the demise of nigral dopaminergic neurons. We provide evidence that the lactacystin model presents with several neuropathological hallmarks of PD related to iron dyshomeostasis and that the novel chelating compounds C6 and C9 can protect against lactacystin-related neurotoxicity.

Item Type: Article
Uncontrolled Keywords: Alpha-synuclein, Dopaminergic, Iron chelators, Lactacystin, Parkinson’s disease, Reactive oxygen species
Subjects: B200 Pharmacology, Toxicology and Pharmacy
Department: Faculties > Health and Life Sciences > Applied Sciences
Depositing User: Elena Carlaw
Date Deposited: 24 Feb 2020 16:51
Last Modified: 23 Mar 2020 16:00
URI: http://nrl.northumbria.ac.uk/id/eprint/42204

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics